The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Luveris Market?
The historical growth can be attributed to several factors, including a rise in infertility rates, the global expansion of IVF clinics, increased awareness regarding hormonal infertility treatments, the availability of recombinant hormone therapies, and advancements within reproductive endocrinology.
Anticipated expansion during the forecast timeframe stems from several factors, including the upward trend in maternal age, greater financial commitments to fertility centers, broader acceptance of tailored reproductive medicine, wider availability of fertility preservation options, and a heightened call for sophisticated hormonal treatments.
Significant developments expected during the forecast period encompass the growing embrace of hormone-centric fertility solutions, increased application of assisted reproductive technologies, a surging need for customized fertility treatment plans, broader deployment of combination hormone therapies, and a sharper emphasis on regulated ovulation induction.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20151&type=smp
What Primary Factors Are Fueling The Expansion Of The Luveris Market?
The luveris market is anticipated to expand due to increasing infertility rates, which signify the proportion of couples or individuals struggling to conceive after approximately a year of unprotected intercourse. These rising rates stem from factors like later childbearing, lifestyle choices, environmental contamination, and underlying medical issues. Luveris (lutropin alfa) addresses infertility in women with insufficient luteinizing hormone (LH) by encouraging ovulation and egg development. An example of this trend is seen in July 2023, when the Human Fertilisation and Embryology Authority, a UK regulator, reported that patients receiving in vitro fertilisation (IVF) at HFEA-licensed fertility centers reached 52,400 in 2023, an increase from prior years. Additionally, donor insemination (DI) treatments led to approximately 820 births, also an increase. Consequently, the growing prevalence of infertility will stimulate the luveris market’s growth.
Luveris Market Driver: Expansion Of Healthcare Infrastructure To Propel Growth Of The Market
The luveris market is projected to grow with the expansion of healthcare infrastructure, encompassing facilities such as hospitals, clinics, medical equipment, personnel, and essential systems for healthcare delivery. This expansion is driven by increasing population demands, an aging demographic, technological progress in healthcare, and the pursuit of improved accessibility and quality of care. Such infrastructural growth benefits luveris by enhancing access to sophisticated fertility treatments and fostering the development of specialized medical centers that employ innovative infertility therapies. For instance, in May 2023, the Department of Health and Social Care, a UK government department, revealed the UK government’s plan to invest over $25.33 billion (£20 billion) into the New Hospital Programme, aiming to establish 40 new hospitals in England by 2030. Thus, the continuous development of healthcare infrastructure will contribute to the luveris market’s expansion.
What Are The Major Segment Categories Within The Luveris Market?
The luveris market covered in this report is segmented –
1) By Formulation: Injectable Formulation (Intravenous), Pre-Filled Syringes
2) By Indication: Treatment Of Hypogonadotropic Hypogonadism, Ovulation Induction, Assisted Reproductive Technology
3) By Route of Administration: Subcutaneous Injection, Intramuscular Injection
4) By Patient Demographics: Adult Female Patients, Adult Male Patients, Couples Undergoing Fertility Treatments
5) By End User: Hospitals, Fertility Clinics, Specialty Pharmacies, Home Healthcare Providers
What Trends Are Affecting The Growth Of The Luveris Market?
A significant trend within the luveris market is the adoption of a strategic investment approach for the development and manufacturing of new medicines. Strategic investments are defined as capital outlays made with the intention of achieving long-term business objectives, such as gaining a competitive advantage, expanding market presence, or enhancing operational capabilities. For instance, in April 2024, Merck KGaA, a Germany-based science and technology company, allocated $316 million (€300 million) towards a new research facility at its international headquarters in Darmstadt, Germany. This advanced research center will concentrate on developing manufacturing solutions for antibodies, mRNA applications, and other products crucial for biotechnological production within Merck’s Life Science business sector. The center will consolidate research on key technologies, including raw materials and processes required for producing antibodies, recombinant proteins, and viral vectors. Additionally, the facility will advance studies in cell culture media, pharmaceutical formulation and purification aids, digital reference materials, and the ongoing enhancement of analytical chromatography, a technique for separating, identifying, and quantifying chemical substances. Research focusing on the mRNA value chain will also be conducted at the new site.
Who Are The Leading Firms Participating In The Luveris Market?
Major companies operating in the luveris market are Merck KGaA
Access The Complete Luveris Market Report:
https://www.thebusinessresearchcompany.com/report/luveris-global-market-report
Which Region Holds The Largest Share In The Luveris Market?
North America was the largest region in the luveris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the luveris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model